Literature DB >> 28409916

Surfactant-Free Aqueous Synthesis of Novel Ba2GdF7:Yb3+, Er3+@PEG Upconversion Nanoparticles for in Vivo Trimodality Imaging.

Yang Feng1, Hongda Chen1, Lina Ma, Baiqi Shao, Shuang Zhao1, Zhenxin Wang, Hongpeng You.   

Abstract

In this work, we developed the surfactant-free aqueous synthesis of novel polyethylene glycol (PEG) coated Ba2GdF7:Yb3+, Er3+ upconversion nanoparticles (named as, Ba2GdF7:Yb3+, Er3+@PEG UCNPs) for in vivo multimodality imaging including upconversion luminescence (UCL), X-ray computed tomography (CT), and T1-weighted magnetic resonance (MR). The as-prepared Ba2GdF7:Yb3+, Er3+@PEG UCNPs not only present bright UCL and reasonably high CT/MR enhancements but also exhibit excellent colloidal stability, inappreciable cytotoxicity, and negligible organ toxicity. In particular, the Ba2GdF7:Yb3+, Er3+@PEG UCNPs emit red UCL with high intensity in the tumor site after intravenous injection via the tail vein of a nude mouse. The Ba2GdF7:Yb3+, Er3+@PEG UCNPs as contrast agents exhibit high-performance for in vivo trimodality (UCL/CT/MR) imaging of a tumor during HepG2 tumor-bearing nude mouse experiments.

Entities:  

Keywords:  Ba2GdF7:Yb3+, Er3+@PEG UCNPs; in vivo trimodality imaging; red emission

Mesh:

Substances:

Year:  2017        PMID: 28409916     DOI: 10.1021/acsami.7b03411

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  Fabrication of NaYF4:Yb3+,Tm3+-modified Ag nanocubes with upconversion luminescence and photothermal conversion properties.

Authors:  Ziyu Chen; Guixia Liu; Zhenhai Cui; Qixin Liu; Feng Hong; Wensheng Yu; Xiangting Dong; Chao Song
Journal:  RSC Adv       Date:  2019-07-03       Impact factor: 3.361

Review 2.  Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment.

Authors:  Gaofeng Liang; Haojie Wang; Hao Shi; Haitao Wang; Mengxi Zhu; Aihua Jing; Jinghua Li; Guangda Li
Journal:  J Nanobiotechnology       Date:  2020-10-29       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.